Again big pharma but we need the help:
Only Phase 2 but: Inhibikase Therapeutics... - Cure Parkinson's
Only Phase 2 but: Inhibikase Therapeutics shares progress on its 'transformational' Parkinson's Disease candidate
Written by
JCRO
To view profiles and participate in discussions please or .
6 Replies
•
Thanks for sharing.
Uplifting! We need help from every angle!
I am currently a cohort in the Roche/Prothena phase 2b trial. While at my last infusion appointment I asked my proctor neurologist what promising clinical trials is he working with and one he was very enthused about was the Inhibikase trial. Exactly what efficacies he was witness to he would not say. Just an anecdote which may prompt some to consider getting involved in the phase 2 trial of the Inhibikasemedication.
• in reply toredhawk1
This trial ?parkinsonsnewstoday.com/202...
Good find
Not what you're looking for?
You may also like...
A (minor) update by Inhibikase Therapeutics on their Phase 2 trial of Risvodetinib (IkT-148009) for Parkinson's Disease.
As of 24 Feb 2024:
- Recruitment continues and is reaching the halfway point (59 of 120);
- 25...
Starting phase 2 trial : Terazosin for Parkinson's Disease (TZ-PD)
Things are moving fast. A Phase II clinical trial for Terazosin in Parkinsons is already being...
I was selected for a clinical trial in Phase 2, for a Mesenchymal Stem Cell Therapy for Parkinson's Disease. Looks promising, any thoughts?
https://www.uth.edu/news/story.htm?id=39f08ac0-b3d0-476d-9ac4-e9c3527f1c94